Projected Cost-Effectiveness for 2 Gene-Drug Pairs Using a Multigene Panel for Patients Undergoing Percutaneous Coronary Intervention

For patients undergoing percutaneous coronary intervention, gene-drug associations exist relevant to first-line treatment options –antiplatelet agent, clopidogrel, and pain medication, tramadol. Knowledge of genotype information may allow for avoidance of adverse drug events during critical clinical windows.

Source: Value in Health - October 15, 2019 Category: International Medicine & Public Health Authors: M. Ragan Hart, Louis P. Garrison, Debra L. Doyle, Gail P. Jarvik, John Watkins, Beth Devine Source Type: research